i.e., TGFβ represses the expression of nutrient receptors, glycolytic capacity and OXPHOS overall reducing NK cell cytotoxicity, supporting that inhibiting TGFβ could restore NK cell function during NAFLD/NASH (63, 77). The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatotic liver disease.